EVFM Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-08-02 | Yip Jenny C. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-31 | Atkinson Katherine Cocca | officer: Chief Commercial Officer | 16,667 | D | 0 | 0.00 | 0.00 | |
| 2022-05-31 | Atkinson Katherine Cocca | officer: Chief Commercial Officer | 0 | D | 4,000 | 6.27 | 25,080.00 | |
| 2022-05-31 | Atkinson Katherine Cocca | officer: Chief Commercial Officer | 0 | D | 6,667 | 7.34 | 48,935.78 | |
| 2022-05-27 | PELLETIER SAUNDRA L | officer: Chief Executive Officer | 236,722 | P-Purchase | A | 141,000 | 0.35 | 49,702.50 |
| 2022-05-04 | O'Brien Anthony Stephen | director: | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-05-04 | Kamdar Kim P. | director: | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-05-04 | Rutherford Colin | director: | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-05-04 | Rarick Lisa Dale | director: | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-05-04 | Greer Gillian | director: | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-02-18 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 516,422 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2022-02-18 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 300,000 | A-Award | A | 300,000 | 0.49 | 147,000.00 |
| 2022-02-18 | File Justin J. | officer: Chief Financial Officer | 810,982 | A-Award | A | 450,000 | 0.00 | 0.00 |
| 2022-02-18 | File Justin J. | officer: Chief Financial Officer | 450,000 | A-Award | A | 450,000 | 0.49 | 220,500.00 |
| 2022-02-18 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 1,435,837 | A-Award | A | 750,000 | 0.00 | 0.00 |
| 2022-02-18 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 750,000 | A-Award | A | 750,000 | 0.49 | 367,500.00 |
| 2021-12-31 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 216,422 | D-Return | D | 120,000 | 0.00 | 0.00 |
| 2021-12-31 | File Justin J. | officer: Chief Financial Officer | 360,982 | D-Return | D | 120,000 | 0.00 | 0.00 |
| 2021-12-31 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 685,837 | D-Return | D | 300,000 | 0.00 | 0.00 |
| 2021-12-20 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 336,422 | P-Purchase | A | 25,000 | 0.39 | 9,725.00 |
| 2021-12-20 | File Justin J. | officer: Chief Financial Officer | 480,982 | P-Purchase | A | 40,594 | 0.37 | 15,019.78 |
| 2021-12-20 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 985,837 | P-Purchase | A | 135,000 | 0.38 | 50,625.00 |
| 2021-07-08 | Barrans Russell | officer: Chief Commercial Officer | 448,554 | F-InKind | D | 19,998 | 0.98 | 19,498.05 |
| 2021-06-18 | Kamdar Kim P. | director | 19,287 | P-Purchase | A | 10,000 | 1.17 | 11,650.00 |
| 2021-06-11 | Rarick Lisa Dale | director | 10,250 | P-Purchase | A | 5,000 | 1.20 | 5,990.00 |
| 2021-06-14 | O'Brien Anthony Stephen | director | 8,140 | P-Purchase | A | 8,140 | 1.31 | 10,663.40 |
| 2021-06-11 | Barrans Russell | officer: Chief Commercial Officer | 468,552 | P-Purchase | A | 18,180 | 1.14 | 20,725.20 |
| 2021-06-10 | File Justin J. | officer: Chief Financial Officer | 440,388 | P-Purchase | A | 24,500 | 1.03 | 25,235.00 |
| 2021-06-10 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 850,837 | P-Purchase | A | 50,000 | 1.03 | 51,500.00 |
| 2021-06-10 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 311,422 | P-Purchase | A | 10,000 | 1.03 | 10,250.00 |
| 2021-05-20 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 301,422 | F-InKind | D | 42,120 | 0.86 | 36,223.20 |
| 2021-05-20 | Barrans Russell | officer: Chief Commercial Officer | 450,372 | F-InKind | D | 31,480 | 0.86 | 27,072.80 |
| 2021-05-20 | Culwell Kelly | officer: Chief Medical Officer | 273,390 | F-InKind | D | 42,061 | 0.86 | 36,172.46 |
| 2021-05-20 | File Justin J. | officer: Chief Financial Officer | 415,888 | F-InKind | D | 42,280 | 0.86 | 36,360.80 |
| 2021-05-20 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 800,837 | F-InKind | D | 105,300 | 0.86 | 90,558.00 |
| 2021-05-12 | Greer Gillian | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-05-12 | Rutherford Colin | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-05-12 | Rarick Lisa Dale | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-05-12 | Kamdar Kim P. | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-05-12 | O'Brien Anthony Stephen | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-05-12 | Hall William Walmsley | director | 90,000 | A-Award | A | 90,000 | 1.25 | 112,500.00 |
| 2021-03-09 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 906,137 | P-Purchase | A | 45,249 | 2.28 | 103,167.72 |
| 2021-02-03 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 860,888 | A-Award | A | 500,000 | 0.00 | 0.00 |
| 2021-02-03 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 700,000 | A-Award | A | 700,000 | 3.25 | 2,275,000.00 |
| 2021-02-03 | Barrans Russell | officer: Chief Commercial Officer | 481,852 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2021-02-03 | Barrans Russell | officer: Chief Commercial Officer | 150,000 | A-Award | A | 150,000 | 3.25 | 487,500.00 |
| 2021-02-03 | File Justin J. | officer: Chief Financial Officer | 458,168 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2021-02-03 | File Justin J. | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 3.25 | 487,500.00 |
| 2021-02-03 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 343,542 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2021-02-03 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 150,000 | A-Award | A | 150,000 | 3.25 | 487,500.00 |
| 2021-02-03 | Culwell Kelly | officer: Chief Medical Officer | 315,451 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2021-02-03 | Culwell Kelly | officer: Chief Medical Officer | 150,000 | A-Award | A | 150,000 | 3.25 | 487,500.00 |
| 2020-11-17 | File Justin J. | officer: Chief Financial Officer | 258,168 | P-Purchase | A | 7,760 | 2.17 | 16,839.20 |
| 2020-11-17 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 143,542 | P-Purchase | A | 9,090 | 2.20 | 19,998.00 |
| 2020-09-10 | Barrans Russell | officer: Chief Commercial Officer | 276,052 | P-Purchase | A | 1,000 | 2.71 | 2,710.00 |
| 2020-09-11 | Barrans Russell | officer: Chief Commercial Officer | 279,052 | P-Purchase | A | 3,000 | 2.08 | 6,240.00 |
| 2020-09-08 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 360,888 | S-Sale | D | 122,500 | 3.26 | 399,350.00 |
| 2020-06-04 | Link Fund Solutions Ltd | 10 percent owner | 0 | S-Sale | D | 9,138,504 | 0.23 | 2,101,855.92 |
| 2020-07-08 | Barrans Russell | officer: Chief Commercial Officer | 275,052 | F-InKind | D | 20,381 | 3.30 | 67,257.30 |
| 2020-06-17 | Rarick Lisa Dale | director | 5,250 | P-Purchase | A | 5,250 | 2.99 | 15,697.50 |
| 2020-06-15 | Hall William Walmsley | director | 5,000 | P-Purchase | A | 5,000 | 2.85 | 14,250.00 |
| 2020-06-15 | Hall William Walmsley | director | 5,000 | P-Purchase | A | 5,000 | 2.85 | 14,250.00 |
| 2020-06-12 | Kamdar Kim P. | director, 10 percent owner: | 9,287 | P-Purchase | A | 5,000 | 2.94 | 14,700.00 |
| 2020-06-12 | File Justin J. | officer: Chief Financial Officer | 250,408 | P-Purchase | A | 8,500 | 3.14 | 26,690.00 |
| 2020-06-04 | ACACIA RESEARCH CORP | 10 percent owner | 1,000 | S-Sale | D | 9,138,504 | 3.21 | 29,325,459.34 |
| 2020-06-04 | ACACIA RESEARCH CORP | 10 percent owner | 9,139,504 | D | 0 | 0.00 | 0.00 | |
| 2020-05-14 | Invesco Ltd. | 10 percent owner | 12,446,479 | J-Other | A | 78,013 | 5.13 | 400,206.69 |
| 2020-05-15 | Invesco Ltd. | 10 percent owner | 12,443,268 | S-Sale | D | 3,211 | 5.04 | 16,183.44 |
| 2020-05-26 | Invesco Ltd. | 10 percent owner | 12,369,454 | S-Sale | D | 73,814 | 5.79 | 427,383.06 |
| 2020-05-26 | Invesco Ltd. | 10 percent owner | 12,369,389 | S-Sale | D | 65 | 5.98 | 388.70 |
| 2020-06-05 | Invesco Ltd. | 10 percent owner | 13,226,532 | P-Purchase | A | 857,143 | 3.50 | 3,000,000.50 |
| 2020-06-05 | File Justin J. | officer: Chief Financial Officer | 237,605 | F-InKind | D | 42,810 | 3.31 | 141,701.10 |
| 2020-06-05 | Culwell Kelly | officer: Chief Medical Officer | 115,451 | F-InKind | D | 31,548 | 3.31 | 104,423.88 |
| 2020-06-05 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 479,085 | F-InKind | D | 85,620 | 3.31 | 283,402.20 |
| 2020-06-05 | Barrans Russell | officer: Chief Commercial Officer | 293,509 | F-InKind | D | 15,455 | 3.31 | 51,156.05 |
| 2020-06-05 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 134,452 | F-InKind | D | 31,590 | 3.31 | 104,562.90 |
| 2020-05-22 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 564,705 | F-InKind | D | 84,525 | 4.99 | 421,779.75 |
| 2020-05-22 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 166,042 | F-InKind | D | 39,487 | 4.99 | 197,040.13 |
| 2020-05-22 | Culwell Kelly | officer: Chief Medical Officer | 146,999 | F-InKind | D | 39,435 | 4.99 | 196,780.65 |
| 2020-05-22 | Barrans Russell | officer: Chief Commercial Officer | 308,964 | F-InKind | D | 19,474 | 4.99 | 97,175.26 |
| 2020-05-22 | File Justin J. | officer: Chief Financial Officer | 280,415 | F-InKind | D | 42,262 | 4.99 | 210,887.38 |
| 2020-05-21 | PDL BIOPHARMA, INC. | 10 percent owner | 0 | J-Other | D | 13,333,334 | 0.00 | 0.00 |
| 2020-05-12 | Rutherford Colin | director | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-12 | O'Brien Anthony Stephen | director | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-12 | Greer Gillian | director | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-12 | Rarick Lisa Dale | director | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-12 | Kamdar Kim P. | director, 10 percent owner: | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-12 | Hall William Walmsley | director | 50,000 | A-Award | A | 50,000 | 5.06 | 253,000.00 |
| 2020-05-06 | Barrans Russell | officer: Chief Commercial Officer | 328,438 | F-InKind | D | 3,802 | 5.24 | 19,922.48 |
| 2020-05-06 | Culwell Kelly | officer: Chief Medical Officer | 186,434 | F-InKind | D | 7,792 | 5.24 | 40,830.08 |
| 2020-05-06 | File Justin J. | officer: Chief Financial Officer | 322,677 | F-InKind | D | 8,420 | 5.24 | 44,120.80 |
| 2020-05-06 | PELLETIER SAUNDRA L | director, officer: Chief Executive Officer | 649,230 | F-InKind | D | 16,905 | 5.24 | 88,582.20 |
| 2020-05-06 | Fitzpatrick Alexander A | officer: General Counsel and Secretary | 205,529 | F-InKind | D | 7,802 | 5.24 | 40,882.48 |
| 2020-04-30 | Culwell Kelly | officer: Chief Medical Officer | 195,226 | S-Sale | D | 1,000 | 4.66 | 4,660.00 |
| 2020-05-01 | Culwell Kelly | officer: Chief Medical Officer | 194,226 | S-Sale | D | 1,000 | 4.75 | 4,750.00 |
| 2020-03-31 | Lynch Thomas G | director | 325,000 | M-Exempt | A | 37,500 | 0.00 | 0.00 |
| 2020-03-31 | Lynch Thomas G | director | 0 | M-Exempt | A | 37,500 | 0.00 | 0.00 |
| 2020-04-01 | Lynch Thomas G | director | 150,000 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2020-02-25 | Rarick Lisa Dale | director | 75,000 | A-Award | A | 75,000 | 5.85 | 438,750.00 |
| 2020-02-25 | Rarick Lisa Dale | director: | 0 | 0 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.